The DOI matches its Crossref record; 235 of the 239 references it cites were found in a registry or an index.
Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
Open accessAbstract
These guidelines were formulated to assist physicians and other health care professionals with various aspects of the administration of outpatient parenteral antimicrobial therapy (OPAT). Although there are many reassuring retrospective studies on the efficacy and safety of OPAT, few prospective studies have been conducted to compare the risks and outcomes for patients who receive treatment as outpatients rather than as inpatients. Because truly evidence-based studies are lacking, the present guidelines are formulated from the collective experience of the committee members and advisors from related organizations. Important aspects of OPAT are described in the text and tables and include the following: The literature supports the effectiveness of OPAT for a wide variety of infections (table 1 and the Appendix). Infections treated with outpatient parenteral antimicrobial therapy (OPAT) and the antibiotics used in 4 studies or sites. A thorough assessment of the patient's general medical condition, the infectious process, and the home situation is necessary before starting therapy (table 2) Specific considerations in evaluating patients for outpatient parenteral antimicrobial therapy (OPAT). Prescribing physicians should be aware of a number of aspects of OPAT which distinguish it from other forms of therapy. These include the required teamwork, communication, monitoring, and outcome measurements (tables 3 and 4). Key elements required for an outpatient parenteral antimicrobial therapy (OPAT) program. Key elements required for evaluating an outpatient parenteral antimicrobial therapy (OPAT) program when the patient is to be referred. The physician has a unique role on the OPAT team, which may also include nursing, pharmacy, and social services. These responsibilities include establishing a diagnosis, prescribing treatment, determining the appropriate site of care, monitoring during therapy, and assuring the overall quality of care. Antimicrobial selection for OPAT is different from that for therapy in the hospital. Once-daily drug administration has many advantages. Potential for adverse effects and the stability of an antimicrobial once it is mixed must be considered (tables 5–7). Properties of commonly prescribed antimicrobials at various temperatures. Suggestions for laboratory parameters that should be monitored weekly during outpatient parenteral antimicrobial therapy (OPAT). The importance of administering the first dose of an antibiotic in a supervised setting is emphasized. Regular clinical and laboratory monitoring of patients receiving OPAT is essential and varies with the antimicrobial chosen (table 8). Outcome measures for outpatient parenteral antimicrobial therapy (OPAT). Outcomes measures should be an integral part of any OPAT program, to assure the effectiveness and quality of care (table 9). Internet resources with information on outpatient parenteral antimicrobial therapy (OPAT). Children receiving OPAT must be considered differently because of their special needs. The practice of administering intravenous antimicrobial therapy in the home and in alternate care settings has grown rapidly since it was first described in 1974 by Rucker and Harrison [1]. The most common infections treated and antimicrobials used by a variety of programs are shown in table 1. In the United States, OPAT is estimated to be a multibillion-dollar-a-year industry and is provided to 1 in 1000 Americans each year [10]. The growth of OPAT has been fueled by a variety of factors including the push for cost containment, the development of antimicrobial agents that can be administered once daily, technological advances in vascular access and infusion devices, increased acceptance of such therapy by both patients and health care personnel, and the availability of reliable and skilled services for OPAT in the community. Although OPAT has become widely accepted as a form of medical therapy (see Appendix), more information is needed regarding its benefits, safety, and limitations. This is especially true with the economic incentives for early discharge that exist for payors. These guidelines update those written in 1997 [11] and are intended to ensure successful implementation of parenteral antimicrobial services for patients in varied community settings, including the home and outpatient facilities, such as physicians' offices, hospital clinics, ambulatory-care centers, day hospitals, and skilled nursing facilities. They have been formulated to incorporate the perspectives of the team of physicians, nurses, pharmacists and other health care professionals necessary for an effective and safe program [6, 8, 12]. Advice and participation were requested of the leading infusion-nurse, pharmacy, and to a on the The were formulated from the collective clinical experience of the of and from the organizations. In the of the and quality of in of OPAT is by a of prospective studies and a number of are The information can a for programs to
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Outpatient parenteral antibiotic therapy (OPAT) is efficacious, safe, and cost-effective for a variety of infections, [323][324][325] including IE that requires prolonged parenteral therapy in hospitalized patients who otherwise no longer require inpatient care but do require continued parenteral antimicrobial therapy.”
Citations
Cites
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,349
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., & Fine, M. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313954 · Cited by 2,286
Medication Errors and Adverse Drug Events in Pediatric Inpatients
Kaushal, R. (2001) · JAMA · doi:10.1001/jama.285.16.2114 · Cited by 1,917
Guidelines for the management of intravascular catheter-related infections
Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S., & Craven, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320001 · Cited by 1,449
Guidelines for the prevention of intravascular catheter-related infections
da Silva, G. D., de Almeida, V. S., Querido, D. L., Esteves, A. P. V. D. S., dos Santos, J. P. O., & Rezende, T. F. (2012) · doi:10.5205/3705 · Cited by 1,119
Niederman, M. S., Bass, J. B., Campbell, G. D., Fein, A. M., Grossman, R. F., Mandell, L. A., Marrie, T. J., Sarosi, G. A., Torres, A., & Yu, V. L. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.5.1418 · Cited by 1,045
(2001) · PsycEXTRA Dataset · doi:10.1037/e548252006-001 · Cited by 1,018
Quality of Care, Process, and Outcomes in Elderly Patients With Pneumonia
Meehan, T. P. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550230056037 · Cited by 919
Guidelines for the Prevention of Intravascular Catheter-Related Infections
O’Grady, N. P., Alexander, M., Dellinger, E. P., Gerberding, J. L., Heard, S. O., Maki, D. G., Masur, H., McCormick, R. D., Mermel, L. A., Pearson, M. L., et al. (2002) · Pediatrics · doi:10.1542/peds.110.5.e51 · Cited by 738
(1995) · American Journal of Infection Control · doi:10.1016/0196-6553(95)90104-3 · Cited by 709
Experience with a once-daily aminoglycoside program administered to 2,184 adult patients
Nicolau, D. P., Freeman, C. D., Belliveau, P. P., Nightingale, C. H., Ross, J. W., & Quintiliani, R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.650 · Cited by 641
Niederman (1993) · Medical Entomology and Zoology · Cited by 624
Infusion Nursing Standards of Practice
Gorski, L. A. (2007) · Journal of Infusion Nursing · doi:10.1097/01.nan.0000270673.13439.95 · Cited by 602
STAPHYLOCOCCUS AUREUS RESISTANT TO VANCOMYCIN???UNITED STATES, 2002
&NA; (2002) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-200203000-00016 · Cited by 395
Cunha, B. A. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70309-6 · Cited by 358
Continuous infusion of beta-lactam antibiotics
Craig, W. A., & Ebert, S. C. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2577 · Cited by 338
Fine, M. J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440220040006 · Cited by 289
Infusion Nursing Standards of Practice
Gorski, L. A. (2007) · Journal of Infusion Nursing · doi:10.1097/00129804-200701000-00004 · Cited by 264
Venous Thrombosis Associated with the Placement of Peripherally Inserted Central Catheters
Allen, A. W., Megargell, J. L., Brown, D. B., Lynch, F. C., Singh, H., Singh, Y., & Waybill, P. N. (2000) · Journal of Vascular and Interventional Radiology · doi:10.1016/s1051-0443(07)61307-4 · Cited by 258
Hospital in the home: a randomised controlled trial
Caplan, G. A., Ward, J. A., Brennan, N. J., Coconis, J., Board, N., & Brown, A. (1999) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb127711.x · Cited by 256
Battleman, D. S., Callahan, M., & Thaler, H. T. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.6.682 · Cited by 248
Risk Factors for the Development of Auditory Toxicity in Patients Receiving Aminoglycosides
Moore, R. D., Smith, C. R., & Lietman, P. S. (1984) · Journal of Infectious Diseases · doi:10.1093/infdis/149.1.23 · Cited by 238
Talcott, J. A., Whalen, A., Clark, J., Rieker, P. P., & Finberg, R. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.1.107 · Cited by 230
Serum Vancomycin Concentrations: Reappraisal of Their Clinical Value
Cantu, T. G., Yamanaka-Yuen, N. A., & Lietman, P. S. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.4.533 · Cited by 230
Racadio, J. M., Doellman, D. A., Johnson, N. D., Bean, J. A., & Jacobs, B. R. (2001) · Pediatrics · doi:10.1542/peds.107.2.e28 · Cited by 230
Non-treatment of defective newborn babies.
SILVERMAN, W. A. (1980) · PubMed · Cited by 227
Outpatient Intravenous Medications in the Management of Cystic Fibrosis
Rucker, R. W., & Harrison, G. M. (1974) · Pediatrics · doi:10.1542/peds.54.3.358 · Cited by 222
Risk factors and treatment outcomes in osteomyelitis
Tice, A. D. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg186 · Cited by 220
Self-citationOutcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy
Tice, A. D., Hoaglund, P. A., & Shoultz, D. A. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00231-6 · Cited by 209
Self-citationPeripherally Inserted Central Catheters in General Medicine
NG, P. K., Ault, M. J., Ellrodt, A. G., & Maldonado, L. (1997) · Mayo Clinic Proceedings · doi:10.4065/72.3.225 · Cited by 203
Is Routine Replacement of Peripheral Intravenous Catheters Necessary?
Bregenzer, T., Conen, D., Sakmann, P., & Widmer, A. F. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.2.151 · Cited by 201
Bertino, J. S., Booker, L. A., Franck, P. A., Jenkins, P. L., Franck, K. R., & Nafziger, A. N. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.1.173 · Cited by 197
Sexton, D. J., Tenenbaum, M. J., Wilson, W. R., Steckelberg, J. M., Tice, A. D., Gilbert, D., Dismukes, W., Drew, R. H., Durack, D. T., & Endocarditis Treatment Consortium Group (1998) · Clinical Infectious Diseases · doi:10.1086/515038 · Cited by 195
Self-citationGraham, D. R., Keldermans, M. M., Klemm, L. W., Semenza, N. J., & Shafer, M. L. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90351-w · Cited by 178
Self-citationTronko, M. D., Bogdanova, T. I., Komissarenko, I. V., Epstein, O. V., Oliynyk, V., Kovalenko, A., Likhtarev, I. A., Kairo, I., Peters, S. B., & LiVolsi, V. A. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990701)86:1<149::aid-cncr21>3.0.co;2-a · Cited by 175
A prospective study of adverse reactions associated with vancomycin therapy
Sorrell, T. C., & Collignon, P. J. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/16.2.235 · Cited by 175
Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients
Mullen, C. A., Petropoulos, D., Roberts, W. M., Rytting, M., Zipf, T. F., Chan, K. W., Culbert, S. J., Danielson, M., Jeha, S. S., Kuttesch, J. F., et al. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990701)86:1<126::aid-cncr18>3.0.co;2-1 · Cited by 160
McCormick, D., Fine, M. J., Coley, C. M., Marrie, T. J., Lave, J. R., Obrosky, D. S., Kapoor, W. N., & Singer, D. E. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00158-8 · Cited by 156
Intravenous Antibiotic Therapy in an Outpatient Setting
Poretz, D. M. (1982) · JAMA · doi:10.1001/jama.1982.03330030042023 · Cited by 152
Dynamic visual acuity: a test for oscillopsia and vestibulo-ocular reflex function.
Demer, J. L., Honrubia, V., & Baloh, R. W. (1994) · PubMed · Cited by 149
Chemaly, R. F., de Parres, J. B., Rehm, S. J., Adal, K. A., Lisgaris, M. V., Katz‐Scott, D. S., Curtas, S., Gordon, S. M., Steiger, E., Olin, J. W., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339808 · Cited by 146
Self-citationWolter, J. M., Bowler, S., Nolan, P., & McCormack, J. G. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10040896 · Cited by 138
Hematologic Effects of Antimicrobials: Focus on the Oxazolidinone Linezolid
Kuter, D. J., & Tillotson, G. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.11.1010.34517 · Cited by 134
Risk factors for toxicity in elderly patients given aminoglycosides once daily
Paterson, D. L., Robson, J. M. B., & Wagener, M. M. (1998) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1998.00224.x · Cited by 132
Andrews, M., & von Reyn, C. F. (2001) · Clinical Infectious Diseases · doi:10.1086/321814 · Cited by 129
Antibiotic Management of Outpatients with Endocarditis Due to Penicillin-Susceptible Streptococci
Stamboulián, D., Bonvehí, P., Arévalo, C. E., Bologna, R., Cassetti, I., Scilingo, V. M., & Efrón, E. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.supplement_2.s160 · Cited by 126
Feasibility of outpatient self-administration of parenteral antibiotics.
Antoniskis, A., Bc, A., Ej, V. V., Jackson, J. M., & Dn, G. (1978) · PubMed Central · Cited by 123
Dosage Adjustments for Antibacterials in Obese Patients: Applying Clinical Pharmacokinetics
Bearden, D. T., & Rodvold, K. A. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200038050-00003 · Cited by 121
Adverse effects of outpatient parenteral antibiotic therapy
Hoffman-Terry, M., Fraimow, H. S., Fox, T., Swift, B. G., & Wolf, J. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00362-3 · Cited by 121
Intravenous Antibiotic Therapy at Home
Stiver, H. G., TELFORD, G. O., MOSSEY, J. M., COTE, D. D., MIDDLESWORTH, E. J. V., TROSKY, S. K., McKAY, N. L., & MOSSEY, W. L. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-5-690 · Cited by 120
Survey of the Use of Peripherally Inserted Central Venous Catheters in Children
Thiagarajan, R. R., Ramamoorthy, C., Gettmann, T., & Bratton, S. L. (1997) · PEDIATRICS · doi:10.1542/peds.99.2.e4 · Cited by 117
Knudsen, J. D., Fuursted, K., Raber, S. R., Espersen, F., & Frimodt‐Møller, N. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1247-1254.2000 · Cited by 115
Practice Guidelines for Community‐Based Parenteral Anti‐Infective Therapy
Williams, D. N., Rehm, S. J., Tice, A. D., Bradley, J. S., Kind, A., & Craig, W. A. (1997) · Clinical Infectious Diseases · doi:10.1086/515552 · Cited by 114
Self-citationHome Intravenous Antibiotic Therapy: A Team Approach
Rehm, S. J., & WEINSTEIN, A. J. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-3-388 · Cited by 112
Self-citationProspective controlled study of home and hospital therapy of cystic fibrosis pulmonary disease
Donati, M. A., Guenette, G., & Auerbach, H. S. (1987) · The Journal of Pediatrics · doi:10.1016/s0022-3476(87)80337-2 · Cited by 109
Haseler, L. J., Arcinue, E. L., Danielsen, E. R., Blüml, S., & Ross, B. D. (1997) · PEDIATRICS · doi:10.1542/peds.99.1.4 · Cited by 109
Home intravenous antibiotic therapy: A safe and effective alternative to inpatient care
Grayson, M. L., Silvers, J., & Turnidge, J. D. (1995) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1995.tb139878.x · Cited by 107
Vancomycin disposition: The importance of age
Cutler, N. R., Narang, P. K., Lesko, L. J., Ninos, M., & Power, M. E. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.260 · Cited by 106
Outpatient Treatment of Pyelonephritis in Pregnancy: A Randomized Controlled Trial
Millar, L. K., WING, D., PAUL, R., & Grimes, D. A. (1995) · Obstetrics and Gynecology · doi:10.1016/0029-7844(95)00244-l · Cited by 105
Mustafa, M. M., Aquino, V. M., Pappo, A. S., Tkaczewski, I., & Buchanan, G. R. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)70339-6 · Cited by 104
Schentag, J. J. (1999) · Journal of Chemotherapy · doi:10.1179/joc.1999.11.6.426 · Cited by 103
Newborn hearing screening: Tobramycin and vancomycin are not risk factors for hearing loss
de Hoog, M., van Zanten, B. A., Hop, W. C. J., Overbosch, E., Weisglas‐Kuperus, N., & van den Anker, J. N. (2003) · The Journal of Pediatrics · doi:10.1067/mpd.2003.mpd037 · Cited by 103
DEGATTA, M., Calvo, M. V. M., Hernández‐Rivas, J. M., Caballero, D. M., Miguel, J. F. S., & Domínguez‐Gil, A. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90060-0 · Cited by 102
Gentamicin-Induced Bilateral Vestibular Hypofunction
Minor, L. B. (1998) · JAMA · doi:10.1001/jama.279.7.541 · Cited by 100
Pea, F., Porreca, L., Baraldo, M., & Furlanut, M. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.3.329 · Cited by 100
Nocardial Menigitis: Case Reports and Review
Bross, J. E., & Gordon, G. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.5.160 · Cited by 100
Pharmacokinetics and Administration Regimens of Vancomycin in Neonates, Infants and Children
Rodvold, K. A., Everett, J. A., Pryka, R. D., & Kraus, D. M. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733010-00004 · Cited by 98
Vinks, A. A. T. M. M., Brimicombe, R. W., Heijerman, H. G., & Bakker, W. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.125 · Cited by 95
DeMaio, J. D., Schwartz, L., Cooley, P., & Tice, A. D. (2001) · Clinical Infectious Diseases · doi:10.1086/324506 · Cited by 90
Self-citationFine, M. J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440220051007 · Cited by 89
Home intravenous antibiotic treatment of patients with cystic fibrosis
Strandvik, B., Hjelte, L., Malmborg, A.-S., & Widén, B. (1992) · Acta Paediatrica · doi:10.1111/j.1651-2227.1992.tb12239.x · Cited by 88
Tulkens, P. M. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.suppl_c.49 · Cited by 87
COMPLICATIONS OF OUTPATIENT PARENTERAL ANTIBIOTIC THERAPY IN CHILDHOOD
Gomez, M. M., Maraqa, N., Alvarez, A., & Rathore, M. H. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200105000-00015 · Cited by 86
Intravenous Antibiotic Therapy at Home
Kind, A. (1979) · Archives of Internal Medicine · doi:10.1001/archinte.1979.03630410023011 · Cited by 82
Early Discharge of Infected Patients Through Appropriate Antibiotic Use
Eron, L. J., & Passos, S. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.1.61 · Cited by 80
Nathwani, D. (2000) · Chemotherapy · doi:10.1159/000048564 · Cited by 79
Tobin, C. M., Darville, J. M., Thomson, A. H., Sweeney, G., Wilson, J. F., MacGowan, A. P., & White, L. O. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf212 · Cited by 76
The Dynamic Illegible E-test: A Technique for Assessing the Vestibulo-ocular Reflex
Longridge, N. S., & Mallinson, A. I. (1987) · Acta Oto-Laryngologica · doi:10.3109/00016488709107283 · Cited by 75
Altered vancomycin dose vs. serum concentration relationship in burn patients
Garrelts, J. C., & Peterie, J. D. (1988) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1988.105 · Cited by 75
Outcome Assessment of Minimizing Vancomycin Monitoring and Dosing Adjustments
Karam, C. M., McKinnon, P. S., Neuhauser, M. M., & Rybak, M. J. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.4.257.30933 · Cited by 75
Safe intravenous antibiotic therapy at home: experience of a UK based programme
Kayley, J., Berendt, A. R., Snelling, M. J. M., Moore, H. A., Hamilton, H. C., Peto, T., Crook, D. W., & Conlon, C. P. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.5.1023 · Cited by 75
Pond, M. N., Newport, M. J., Joanes, D. N., & Conway, S. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07091640 · Cited by 74
The Future History of Home Care and Physician House Calls in the United States
Leff, B. A., & Burton, J. (2001) · The Journals of Gerontology Series A · doi:10.1093/gerona/56.10.m603 · Cited by 72
Tip Location of Peripherally Inserted Central Catheters
(1998) · Journal of Vascular Access Devices · doi:10.2309/108300898776087341 · Cited by 72
Home intravenous antibiotic treatment in cystic fibrosis.
Gilbert, J., Robinson, T., & Littlewood, J. M. (1988) · Archives of Disease in Childhood · doi:10.1136/adc.63.5.512 · Cited by 70
Montauk, S. L. (1998) · PubMed · Cited by 70
Improving Patient Outcomes through CQI: Vascular Access Planning
Barton, A. J., Danek, G. D., Johns, P., & Coons, M. (1998) · Journal of Nursing Care Quality · doi:10.1097/00001786-199812000-00010 · Cited by 68
Changes in Vancomycin Pharmacokinetics in Critically Ill Infants
Gous, A. G. S., Dance, M., Lipman, J., Luyt, D. K., Mathivha, R. L., & Scribante, J. (1995) · Anaesthesia and Intensive Care · doi:10.1177/0310057x9502300603 · Cited by 68
Ambulatory antimicrobial use: the value of an outcomes registry
Nathwani, D. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.1.149 · Cited by 65
Tice, A. D. (1995) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01690748 · Cited by 64
Self-citationAn Office Model of Outpatient Parenteral Antibiotic Therapy
Tice, A. D. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.supplement_2.s184 · Cited by 62
Self-citationJames, L., Bledsoe, L. D., & HADAWAY, L. C. (1993) · PubMed · Cited by 61
Financial Impact of a Home Intravenous Antibiotic Program on a Medicare Managed Care Program
Dalovisio, J. R., Juneau, J., Baumgarten, K. L., & Kateiva, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313755 · Cited by 61
Self-citationThe Incidence of Aminoglycoside Antibiotic-Induced Hearing Loss
Brummett, R. E., & Morrison, R. B. (1990) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1990.01870040028008 · Cited by 60
Craig, W. A. (1995) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01690745 · Cited by 60
SELF-ADMINISTERED HOME INTRAVENOUS ANTIBIOTIC THERAPY IN BRONCHIECTASIS AND ADULT CYSTIC FIBROSIS
Winter, R. J. D., Deacock, S. J., George, R. J. D., Shee, C. D., & Geddes, D. M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91829-4 · Cited by 60
Ceftriaxone Therapy for Staphylococcal Osteomyelitis: A Review
Guglielmo, B. J., Luber, A., Paletta, D., & Jacobs, R. A. (2000) · Clinical Infectious Diseases · doi:10.1086/313620 · Cited by 59
Outpatient therapy of serious pediatric infections with ceftriaxone
Bradley, J. S., Ching, D., & Phillips, S. E. (1988) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198803000-00005 · Cited by 59
Self-citationBaumgartner, J. D., & Glauser, M. P. (1983) · Archives of Internal Medicine · doi:10.1001/archinte.143.10.1868 · Cited by 58
CEFTRIAXONE AND OUTPATIENT TREATMENT OF INFECTIVE ENDOCARDITIS
Francioli, P. B. (1993) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30508-0 · Cited by 57
Lack of Vancomycin-associated Nephrotoxicity in Newborn Infants: A Case–Control Study
Bhatt‐Mehta, V., Schumacher, R. E., Faix, R. G., Leady, M. A., & Brenner, T. L. (1999) · PEDIATRICS · doi:10.1542/peds.103.4.e48 · Cited by 56
Incidence of Neutropenia during Treatment of Bone-Related Infections with Piperacillin-Tazobactam
Peralta, G., Sanchez, M. B., Mesones, M. P. R., Pena, M. Á., Tejero, M. Á., & Arjona, R. (2003) · Clinical Infectious Diseases · doi:10.1086/379519 · Cited by 55
Guay, D. R. P., Vance‐Bryan, K., Gilliland, S. S., Rodvold, K. A., & Rotschafer, J. C. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb01922.x · Cited by 54
Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis
Graninger, W. B., Wenisch, C., Wiesinger, E., Menschik, M., Karimi, J., & Presterl, E. (1995) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01690746 · Cited by 54
Hepatotoxicity of antibiotics.
Hautekeete, M. L. (1995) · PubMed · Cited by 53
Individualizing Vancomycin Dosage Regimens: One- Versus Two-Compartment Bayesian Models
Pryka, R. D., Rodvold, K. A., Garrison, M. W., & Rotschafer, J. C. (1989) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198907000-00013 · Cited by 53
Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settings
Eron, L. J., Park, C. H., Hixon, D. L., Goldenberg, R. I., & Poretz, D. M. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.5.731 · Cited by 53
Outpatient Parenteral Antimicrobial Therapy for Central Nervous System Infections
Tice, A. D., Strait, K., Ramey, R., & Hoaglund, P. A. (1999) · Clinical Infectious Diseases · doi:10.1086/313503 · Cited by 53
Self-citationVancomycin Pharmacokinetics in Neonates and Infants: A Retrospective Evaluation
Reed, M. D., Asbury, W. H., Darsey, E., Rose, W. B., Murphy, J. E., Buffington, D. E., & Capers, C. C. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700417 · Cited by 52
Mullen, C. A., Petropoulos, D., Roberts, W. M., Rytting, M., Zipf, T. F., Chan, K. W., Culbert, S. J., Danielson, M., Jeha, S. S., Kuttesch, J. F., et al. (1999) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199905000-00009 · Cited by 52
Dagan, R., Phillip, M., Watemberg, N. M., & Kassis, I. (1987) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198706120-00002 · Cited by 51
Evaluation of a Home Intravenous Antibiotic Program in Pediatric Oncology
Wiernikowski, J. T., Rothney, M., Dawson, S., & Andrew, M. (1991) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199122000-00006 · Cited by 51
Maraqa, N., Gomez, M. M., Rathore, M. H., & Alvarez, A. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338047 · Cited by 50
Infusion therapy in clinical practice
Hankins, J. (2001) · Saunders eBooks · Cited by 49
Kane, R. E., Jennison, K., Wood, C., Black, P., & Herbst, J. J. (1988) · Pediatric Pulmonology · doi:10.1002/ppul.1950040205 · Cited by 47
Tice, A. D. (2000) · Chemotherapy · doi:10.1159/000048563 · Cited by 47
Self-citationNs, L., & Mallinson, A. I. (1987) · PubMed · Cited by 45
Hooker, L., & Kohler, J. (1999) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(199906)32:6<421::aid-mpo5>3.0.co;2-d · Cited by 44
Nathwani, D., & Conlon, C. P. (1998) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1998.tb00413.x · Cited by 43
OUTPATIENT INTRAVENOUS ANTIBIOTIC THERAPY IN MEDICARE PATIENTS: COST-SAVINGS ANALYSIS
Hindes, R. G., Winkler, C., Kane, P., & Kunkel, M. J. (1995) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-199505000-00016 · Cited by 43
Self-citationIntravenous antibiotic therapy in ambulatory pediatric patients
Goldenberg, R. I., Poretz, D. M., Eron, L. J., Rising, J., & Sparks, S. (1984) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198411000-00006 · Cited by 43
Home‐based treatment of cellulitis with twice‐daily cefazolin
Leder, K. S., Grayson, M. L., & Turnidge, J. D. (1998) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1998.tb123398.x · Cited by 43
Auble, T. E., Yealy, D. M., & Fine, M. J. (1998) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70208-7 · Cited by 41
Pharmacokinetic parameters of vancomycin for therapeutic regimens in neutropenic adult patients
Normand, Y. L., Milpied, N. J., Kerguéris, M.-F., & Harousseau, J. (1994) · International Journal of Bio-Medical Computing · doi:10.1016/0020-7101(94)90102-3 · Cited by 41
On cancer control and the adolescent
Barr, R. D. (1999) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(199906)32:6<404::aid-mpo2>3.0.co;2-f · Cited by 40
OUTPATIENT PARENTERAL ANTIMICROBIAL THERAPY FOR OSTEOMYELITIS
Tice, A. D. (1998) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70027-1 · Cited by 40
Self-citationRybak, M. J., & Boike, S. C. (1986) · Annals of Pharmacotherapy · doi:10.1177/106002808602001003 · Cited by 40
Home intravenous antibiotic therapy (HIVAT): indications, patients and antimicrobial agents
Williams, D. N. (1995) · International Journal of Antimicrobial Agents · doi:10.1016/0924-8579(94)00046-w · Cited by 39
Self-citationHome Intravenous Antibiotic Therapy for Patients with Infective Endocarditis
Huminer, D., Bishara, J., & Pitlik, S. D. (1999) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/pl00015014 · Cited by 39
Kralovicová, K., Spanik, S., Halko, J., Netriová, J., Mrazova-Studena, M., Novotný, J., Grausova, S., Koren, P., Krupova, I., Demitrovicova, A., et al. (1997) · Journal of Chemotherapy · doi:10.1179/joc.1997.9.6.420 · Cited by 38
Nathwani, D., Morrison, J., Seaton, R. A., France, A. J., Davey, P. G., & Gray, K. (1999) · PubMed · Cited by 38
Daily dosage of aminoglycosides.
Urban, A. W., & Craig, W. A. (1997) · PubMed · Cited by 38
OUTPATIENT INTRAVENOUS ANTIBIOTIC THERAPY FOR ENDOCARDITIS
Rehm, S. J. (1998) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70026-x · Cited by 37
Self-citationPharmacokinetic Monitoring of Nephrotoxic Antibiotics in Surgical Intensive Care Patients
Reed, R. L., WU, A. H., MILLER-CROTCHETT, P., Crotchett, J., & Fischer, R. P. (1989) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-198911000-00002 · Cited by 37
Intramuscular ceftriaxone in home parenteral therapy
Russo, T. A., Cook, S., & Gorbach, S. L. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.9.1439 · Cited by 37
Successful administration of quinupristin/dalfopristin in the outpatient setting
Rehm, S. J., Graham, D. R., SRINATH, L., Prokocimer, P., Richard, M. P., & Talbot, G. H. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.5.639 · Cited by 37
Self-citationTice, A. D. (1993) · Hospital Practice · doi:10.1080/21548331.1993.11442928 · Cited by 37
Self-citationAmbulatory treatment with ceftriaxone in febrile neutropenic children.
Kaplinsky, C., Drucker, M. M., Goshen, J., Tamary, H., Cohen, I. J., & Zaizov, R. (1994) · PubMed · Cited by 37
TREATMENT OF BACTERIAL MENINGITIS
(1936) · The Lancet · doi:10.1016/s0140-6736(01)36654-0 · Cited by 37
Home Intravenous Antibiotic Therapy Using a Programmable Infusion Pump
Williams, D. N. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390050115023 · Cited by 36
Self-citationThe Infusion Center: A Model for Outpatient Parenteral Antibiotic Therapy
Poretz, D. M. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.supplement_2.s142 · Cited by 35
Davey, P. G., Jabeen, F., Harpur, E. S., Shenoi, P. M., & Geddes, A. M. (1983) · The Journal of Laryngology & Otology · doi:10.1017/s0022215100093762 · Cited by 35
Bradley, J. S., Behrendt, C. E., Arrieta, A. C., Harrison, C. J., Loeffler, A. M., Iaconis, J. P., & Wald, E. R. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200101000-00005 · Cited by 34
Self-citationTherapeutic Drug Monitoring of Vancomycin in a Morbidly Obese Patient
Penzak, S. R., Gubbins, P. O., Rodvold, K. A., & Hickerson, S. L. (1998) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199806000-00005 · Cited by 34
Outpatient management of acute mastoiditis with periosteitis in children
Niv, A., Nash, M., Peiser, J. G., Dagan, R., Einhorn, M. S., Leiberman, A., & Fliss, D. M. (1998) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/s0165-5876(98)00110-4 · Cited by 34
Long-term Intravenous Antibiotic Therapy in Chronic Osteomyelitis
Wagner, D. K., Collier, B. D., & Rytel, M. W. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.1985.00360060139022 · Cited by 33
Vancomycin administration in continuous ambulatory peritoneal dialysis: The risk of ototoxicity
Gendeh, B. S., Gibb, A. G., Aziz, N. S., Kong, N. C. T., & Zahir, Z. M. (1998) · Otolaryngology · doi:10.1177/019459989811800420 · Cited by 32
Changes in Vancomycin Pharmacokinetics During Treatment
Pou, L., Rosell, M., López, R. M., & Pascual, C. (1996) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199604000-00007 · Cited by 32
Nathwani, D., Moitra, S., Dunbar, J., Crosby, G., Peterkin, G., & Davey, P. G. (1998) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1998.tb08909.x · Cited by 32
Outpatient treatment of endocarditis in a clinic-based program in Argentina
Stamboulián, D. (1995) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01690747 · Cited by 31
Special Considerations for Monitoring Vancomycin Concentrations in Pediatric Patients
Miles, M. V., Li, L., Lakkis, H. D., Youngblood, J., & McGinnis, P. J. (1997) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199706000-00004 · Cited by 31
Use of Outpatient Parenteral Antibiotic Therapy in a Health Maintenance Organization
Grizzard, M., Harris, G., & Karns, H. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.supplement_2.s174 · Cited by 31
Pharmacoeconomic Considerations in the Ambulatory Use of Parenteral Cephalosporins
Tice, A. D. (2000) · Drugs · doi:10.2165/00003495-200059003-00004 · Cited by 30
Self-citationBradley, J. S., Ching, D., Wilson, T. A., & Compogiannis, L. S. (1992) · Clinical Pediatrics · doi:10.1177/000992289203100502 · Cited by 30
Self-citationLong-term care facilities as sources of antibiotic-resistant nosocomial pathogens
Crossley, K. (2001) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200108000-00010 · Cited by 30
Cefonicid in a Once-Daily Regimen for Treatment of Osteomyelitis in an Ambulatory Setting
Kunkel, M. J., & Iannini, P. B. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_4.s865 · Cited by 29
Self-citationHome Treatment of Pulmonary Infections in Cystic Fibrosis
Kuzemko, J. A. (1988) · CHEST Journal · doi:10.1378/chest.94.2_supplement.162s · Cited by 29
Nørgård, B. M., Sørensen, H. T., Jensen, E. S., Faber, T., Schønheyder, H. C., & Nielsen, G. L. (2002) · Journal of Infection · doi:10.1053/jinf.2002.1037 · Cited by 28
PATIENT SELECTION IN OUTPATIENT PARENTERAL ANTIMICROBIAL THERAPY
Nolet, B. R. (1998) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70023-4 · Cited by 26
Combined ceftriaxone and surgical therapy for osteomyelitis in hospital and outpatient settings.
Lj, E., Ri, G., & Poretz, D. M. (1984) · PubMed · Cited by 26
Sahu, S., Bapna, A., Pai, S., Nair, C. N., Kurkure, P. A., & Advani, S. H. (1997) · Pediatric Hematology and Oncology · doi:10.3109/08880019709009490 · Cited by 25
Home care: The next frontier of pediatric practice
Goldberg, A. I., Gardner, H. G., & Gibson, L. E. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(06)80163-0 · Cited by 25
Home care in cystic fibrosis patients
van Aalderen, W. M. C., Mannes, G. P. M., Bosma, E., Roorda, R. J., & Heymans, H. S. A. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08010172 · Cited by 25
Outpatient Intravenous Antibiotics for Chronic Rhinosinusitis
Gross, N. D., McInnes, R. J. A., & Hwang, P. H. (2002) · The Laryngoscope · doi:10.1097/00005537-200210000-00009 · Cited by 25
Out-patient parenteral antibiotic therapy (OPAT): clinical outcomes and adverse events.
Berman, S., & Johnson, E. W. (2001) · PubMed · Cited by 25
ASHP Guidelines on the Pharmacist’s Role in Home Care.
(2000) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/57.13.1252 · Cited by 25
Saunders Infection Control Reference Service
O’Keefe, P., & VonBehren, S. M. B. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-8-199804150-00037 · Cited by 24
Simulation of Vancomycin Peak and Trough Concentrations Using Five Dosing Methods in 37 Patients
Zokufa, H. Z., Rodvold, K. A., Blum, R. A., Riff, L. J. M., Fischer, J. H., Crossley, K., & Rotschafer, J. C. (1989) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1989.tb04097.x · Cited by 23
Early Discharge With Home Antibiotic Therapy in the Treatment of Neonatal Infection
Wagner, C. L., Wagstaff, P., Cox, T. H., & Annibale, D. J. (2000) · Journal of Perinatology · doi:10.1038/sj.jp.7200386 · Cited by 23
Home intravenous antimicrobial therapy provided by a community hospital and a university hospital
Smego, R. A., & Gainer, R. B. (1985) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/42.10.2185 · Cited by 23
Self-citationSelection and Training of Patients for Outpatient Intravenous Antibiotic Therapy
Brown, R. B. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.supplement_2.s147 · Cited by 23
Johansson, E., Björkholm, M., Wredling, R., Kalin, M., & Engervall, P. (2001) · Supportive Care in Cancer · doi:10.1007/s005200100247 · Cited by 22
Poretz, D. M. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90284-4 · Cited by 21
The appropriateness of initial vancomycin dosing.
Rodman, D. P., McKnight, J. T., Rogers, T., & Robbins, M. (1994) · PubMed · Cited by 20
Esposito, S., Noviello, S., Ianniello, F., & D'Errico, G. (2000) · PubMed · doi:10.1179/joc.2000.12.1.88 · Cited by 20
PERIPHERALLY INSERTED CENTRAL VENOUS CATHETERS FOR OUTPATIENT INTRAVENOUS ANTIBIOTIC THERAPY
Tice, A. D., Bonstell, R. P., Marsh, P. K., Craven, P. C., McEniry, D. W., & Harding, S. (1993) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-199305000-00005 · Cited by 20
Self-citationManagement of Endocarditis: Outpatient Parenteral Antibiotic Treatment in Argentina
Lopardo, G. D. (2000) · Chemotherapy · doi:10.1159/000048565 · Cited by 20
Cellular expression of MDM2 and p53 in childhood leukemias with poor prognosis
Gustafsson, B. M., Christenson, B., Gustafsson, B., Hjalmar, V., & Winiarski, J. H. (2000) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(200002)34:2<87::aid-mpo2>3.0.co;2-f · Cited by 20
Hjelte, L., Widén, B., Malmborg, A. S., FREYSCHUSS, U., & Strandvik, B. (1988) · PubMed · Cited by 20
Intravenous Antibiotics at Home
HARRIS, L. F., BUCKLE, T. F., & COFFEY, F. L. (1986) · Southern Medical Journal · doi:10.1097/00007611-198602000-00014 · Cited by 20
Garrelts, J. C., Ast, D., LaRocca, J., Smith, D. F., & Peterie, J. D. (1988) · PubMed · Cited by 19
Effect of Renal Impairment on the Pharmacokinetics of Grepafloxacin
Efthymiopoulos, C., Bramer, S. L., Maroli, A. N., & Gambertoglio, J. G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199700331-00007 · Cited by 19
The importance of teamwork for outpatient parenteral antibiotic therapy
Tice, A. D. (1995) · International Journal of Antimicrobial Agents · doi:10.1016/0924-8579(94)00052-v · Cited by 19
Self-citationONCE-DAILY AMINOGLYCOSIDE TREATMENT
Dew, R. B., & Susla, G. M. (1996) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-199601000-00004 · Cited by 19
Infection Due to Leoconostoc Species
Golledge, C. L. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.5.184 · Cited by 19
Efficacy and safety of intravenous cefotaxime for treating pneumonia in outpatients
Morales, J. O., & Snead, H. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90285-2 · Cited by 18
Health Maintenance Organization
Miller, Z. (1993) · Hospital Practice · doi:10.1080/21548331.1993.11442948 · Cited by 18
ASHP Guidelines: Minimum Standard for Home Care Pharmacies
McKinnon, B., Bertch, K. E., Carey, L. P., Leach, T. D., Pelham, L. D., & Swift, B. G. (1999) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/56.7.629 · Cited by 17
Bradley, J. S., Farhat, C., Stamboulián, D., et al. (1994) · PubMed · Cited by 17
Self-citationMorales, J. O., & Behren, L. A. V. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90282-8 · Cited by 17
Serial trough and peak amikacin levels in plasma as predictors of nephrotoxicity
Contreras, A., Gamba, G., Cortés, J., Santiago, Y., Nares, F., Jiménez‐Sánchez, G., Bobadilla, J. R., López, G., Valadez, A., & Espinosa, A. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.6.973 · Cited by 17
Bradley, J. S., Farhat, C. K., Stamboulián, D., Branchini, O. A., Debbag, R., & Compogiannis, L. S. (1994) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199408000-00009 · Cited by 17
Self-citationEndocarditis : medical and surgical management
Magilligan, D. J., & Quinn, E. L. (1986) · M. Dekker eBooks · Cited by 16
Home antibiotic therapy for streptococcal endocarditis: A call for a controlled trial
Colford, J. M., Corelli, R. L., Ganz, J. W., Guglielmo, B. J., & Jacobs, R. A. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90131-8 · Cited by 16
Outpatient parenteral antimicrobial therapy: Experience in a large teaching hospital
Wiselka, M. J., & Nicholson, K. G. (1997) · Journal of Infection · doi:10.1016/s0163-4453(97)91073-2 · Cited by 16
Home Intravenous Antibiotic Therapy Programme, 1999
Steinmetz, D., Berkovits, E., Edelstein, H., FLATAU, E., Almany, A., & Raz, R. (2001) · Journal of Infection · doi:10.1053/jinf.2001.0824 · Cited by 15
Research works printed but not linked: 28
- Winters, 1992, Home infusion therapy: a service and demographic profile: a report for the National Alliance for Infusion Therapy, 1
- Hankwitz, 1994, The expanding and increasingly important role of the home health care agency medical director, Am Ac Home Care Phys Newsletter, 6, 8
- Tice, 1993, Growing pains in outpatient intravenous antibiotic therapy, Infect Dis Clin Pract, 1, 74
- 1986, Wickline v State of California, 228 Cal. Rptr. 661, 192. Cap. App. 3d 1630
- 1981, Physicians, surgeons and other healers. American Jurisprudence, 226
- Tice, 1997, Delivery models for outpatient parenteral antimicrobial therapy. In: Outpatient parenteral antimicrobial therapy: current status, 7
- Residency Review Committee, Specific program content. CAAR Program Information from Workshop for Internal Medicine Subspecialty Residencies in Infectious Disease. 11. 2001. American Board of Internal Medicine. Ref Type: Conference Proceeding.
- Lonsway, 2001, Intravenous therapy in the home, 501
- Mortlock, 2001, Intravenous therapy in the alternative care setting, 535
- Skokal, 2000, IV push at home?, RN, 63, 26
- Tice, 2002, Adverse effects with intravenous antibiotics with OPAT
- Rehm, 2000, Rates of adverse events associated with community-based parenteral anti-infective therapy, J Clin Outcomes Manage, 7, 23
- Martinelli, 1988, Aminoglycoside questionnaire results
- Hautekeete, 1995, Hepatotoxicity of antibitoics, Acta Gastroenterol Belg, 58, 290
- 1999, 2000–2001 Comprehensive accreditation manual for ambulatory care
- Barrell, 1998, ORYX: outcomes measurement and accreditation, Infusion, May, 37
- Poole, 1998, Outcomes measurements: making sense of the data, Infusion, May, 25
- Tice, 2000, Documenting the value of OPAT: outcomes studies and patient registries, Can J Infect Dis, 10, 45
- Tice, 2000, Outcomes registry for outpatient IV antimicrobial therapy, Infusion, May, 27
- Outpatient Parenteral Antimicrobial Therpay Outcomes Registry Web site
- Tice, 2003, Reasons for failures with OPAT [abstract 293]
- Arditi, 1990, Convalescent outpatient therapy for selected children with acute bacterial meningitis, Semin Pediatr Infect Dis, 1, 404
- Sudela, 1990, Nursing aspects of pediatric home infusion therapy for the treatment of serious, Semin Pediatr Infect Dis, 1, 306
- Tice, 2003, OPAT outcomes registry evaluaton of diabetic extremity infections [abstract 291]
- Wai, 1999, A cost analysis of an outpatient parenteral antibiotic program (OPAT): a Canadian teaching hospital and ministry of health perspective, 133
- Tice, 1997, Osteomyelitis
- Rehm, 1992, Home intravenous antibiotic therapy (HIVAT) for endocarditis
- Gentry, 1989, New approches to the diagnosis and treatment of infective endocarditis, Texas Heart Institute J, 16, 250
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Osmon, D. R., Berbari, E. F., Berendt, A. R., Lew, D., Zimmerli, W., Steckelberg, J. M., Rao, N., Hanssen, A., & Wilson, W. R. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis803 · Cited by 2,266
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Bradley, J. S., Byington, C. L., Shah, S. S., Alverson, B., Carter, E. R., Harrison, C., Kaplan, S. L., Mace, S. E., McCracken, G. H., Moore, M. R., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir531 · Cited by 1,919
Self-citation
Metadata
- Authors
- Tice, A. D., Rehm, S. J., Dalovisio, J. R., Bradley, J. S., Martinelli, L. P., Graham, D. R., Gainer, R. B., Kunkel, M. J., Yancey, R. W., & Williams, D. N.
- Affiliations
- University of Hawaiʻi at Mānoa (US)
- Cleveland Clinic (US)
- Ochsner Medical Center (US)
- Rady Children's Hospital-San Diego (US)
- Consultants in Infectious Diseases, Lubbock, Texas
- Springfield Clinic (US)
- Morgantown Internal Medicine Group, Morgantown, West Virginia
- Pfizer (United States) (US)
- Florida Infection Physicians, Gainsville
- Hennepin County Medical Center (US)
- Corresponding author
- Tice, Alan D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-06-15
- Volume
- 38
- Issue
- 12
- Pages
- 1651-1671
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2141994303
- Cited by
- 532
- References
- 239
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 18 · 2023: 17 · 2022: 21 · 2021: 21 · 2020: 31 · 2019: 38 · 2018: 48 · 2017: 40 · 2016: 43 · 2015: 32 · 2014: 36 · 2013: 31 · 2012: 21
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Keywords
- outpatient parenteral antimicrobial therapy, outpatient antibiotic therapy, patient selection, antimicrobial selection, once-daily dosing, drug stability, laboratory monitoring, adverse drug reactions, quality of care, multidisciplinary team
- MeSH terms
- Adult, Anti-Bacterial Agents, Child, Home Care Services, Humans, Infusions, Intravenous, Outpatients, Patient Care Team, Pediatrics, Drug Monitoring, Outcome Assessment, Health Care, Patient Selection, Home Infusion Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.